000 02381 a2200673 4500
005 20250515190918.0
264 0 _c20100503
008 201005s 0 0 eng d
022 _a1096-0961
024 7 _a10.1016/j.bcmd.2009.09.006
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHollak, Carla E M
245 0 0 _aForce majeure: therapeutic measures in response to restricted supply of imiglucerase (Cerezyme) for patients with Gaucher disease.
_h[electronic resource]
260 _bBlood cells, molecules & diseases
_cJan 2010
300 _a41-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _a1-Deoxynojirimycin
_xanalogs & derivatives
650 0 4 _aAfrica, Northern
_xepidemiology
650 0 4 _aCompassionate Use Trials
650 0 4 _aDrug Contamination
_xprevention & control
650 0 4 _aDrugs, Investigational
_xsupply & distribution
650 0 4 _aEnzyme Inhibitors
_xtherapeutic use
650 0 4 _aEnzyme Replacement Therapy
_xstatistics & numerical data
650 0 4 _aEquipment Contamination
650 0 4 _aEurope
_xepidemiology
650 0 4 _aGaucher Disease
_xdrug therapy
650 0 4 _aGlucosylceramidase
_xsupply & distribution
650 0 4 _aGuidelines as Topic
650 0 4 _aHealth Care Rationing
650 0 4 _aHealth Priorities
650 0 4 _aHumans
650 0 4 _aInternational Cooperation
650 0 4 _aMiddle East
_xepidemiology
650 0 4 _aRecombinant Proteins
_xsupply & distribution
650 0 4 _aVesivirus
700 1 _avom Dahl, Stephan
700 1 _aAerts, Johannes M F G
700 1 _aBelmatoug, Nadia
700 1 _aBembi, Bruno
700 1 _aCohen, Yossi
700 1 _aCollin-Histed, Tanya
700 1 _aDeegan, Patrick
700 1 _avan Dussen, Laura
700 1 _aGiraldo, Pilar
700 1 _aMengel, Eugen
700 1 _aMichelakakis, Helen
700 1 _aManuel, Jeremy
700 1 _aHrebicek, Martin
700 1 _aParini, Rosella
700 1 _aReinke, Jörg
700 1 _adi Rocco, Maja
700 1 _aPocovi, Miguel
700 1 _aSa Miranda, Maria Clara
700 1 _aTylki-Szymanska, Anna
700 1 _aZimran, Ari
700 1 _aCox, Timothy M
773 0 _tBlood cells, molecules & diseases
_gvol. 44
_gno. 1
_gp. 41-7
856 4 0 _uhttps://doi.org/10.1016/j.bcmd.2009.09.006
_zAvailable from publisher's website
999 _c19200191
_d19200191